Greg Medlock
@MedlockGreg
Followers
134
Following
380
Media
5
Statuses
82
Sr Director R&D @vedantabio. Interested in drug development, infection prevention, microbiome, systems biology, & urban policy. On Bsky now.
Cambridge, MA
Joined May 2023
0
2
2
I'm speaking at Beyond Antibiotics: Emerging Strategies for Combating Bacterial Infection @KeystoneSymp May 4-7, 2026. Abstract and scholarship submissions are open through Jan 7. Please encourage those in your network working on novel infection prevention/treatment to submit!
1
3
2
Love the science being done on creatine right nowβ¦ but itβs very quickly affecting the supply-demand equation. https://t.co/1gG46y19yt
alz-journals.onlinelibrary.wiley.com
BACKGROUND Preclinical studies suggest that creatine monohydrate (CrM) improves cognition and Alzheimer's disease (AD) biomarkers. However, there is currently no clinical evidence demonstrating the...
0
0
0
Itβs World AMR Awareness Week! Watch the video below to hear CARB-X Chief of R&D Erin Duffy highlight the progress of the portfolio including interviews with product developers @dayzerodx and @VedantaBio. #WAAW π Watch here:
1
2
4
Iβve made a starter pack on βthe other siteβ for people in the drug development ecosystem. Please reach out to be added or suggest others:
0
0
1
If you're following biotech news & starting to become more active on Bluesky, one suggestion I have is @TheCrick's @simonbayly who has also put together a "biotech starter pack." He's @simonbayly.bsky.social or search for his name. The hashtag over there is #biosky
0
1
3
Phenotypic high-throughput screening identifies modulators of gut microbial choline metabolism https://t.co/qbflyF6JLn
#biorxiv_micrbio
0
2
4
Is the future of inflammatory bowel disease therapy immune therapy plus #microbiome therapy? Here is a patient with ulcerative colitis refectory to 3 biologics treated with fecal microbiota transplantation and vedolizumab. #MedTwitter #GITwitter #FMT
https://t.co/1EJHUCmTqb
7
15
80
My team at @VedantaBio is recruiting a molecular biologist to work on development and qualification of assays for characterizing defined bacterial consortia. Please share with your network and consider applying! https://t.co/M2mSknxtYt
job-boards.greenhouse.io
0
3
3
We are recruiting a Bioinformatician to join our Systems Biology team at Vedanta. Come work with us to advance defined bacterial consortia as a new drug modality! https://t.co/oFSBVw9IU8
job-boards.greenhouse.io
0
4
4
Barely a week after John Corcoran was killed when a driver hopped the curb on @MassDCR-managed Memorial Drive and hit him on the sidewalk, @MassGov retweeted this.
October is #PedestrianSafetyMonth and we want to share some important traits that #Pedestrians everywhere should have while interacting with traffic! #PedestrianSafety matters! Let's stay safe and alert! #TrafficSafety #EndTheStreakTX π¦πΆββοΈ Thank you @txdot for these reminders!
0
0
2
Great seeing @bernatolle finally chatting with @bradloncar !
πππ₯π€π’π§π πππ’ππ§ππ: @VedantaBio's founder and CEO @bernatolle shares an expert take on microbiome drug development. Full video: https://t.co/a8c1nqvuF6
0
0
6
Long-read metagenomics empowers precise tracking of bacterial strains and their genomic changes after fecal microbiota transplantation https://t.co/pgwL97EMA7
#biorxiv_micrbio
0
2
8
Microtwitter, I'm looking for equivalents for a discontinued square well 96-well plate. Its superpower is that it fits in most platereaders but it can accommodate 500uL sample volumes. It was featured in this pub on automated bacterial culture systems: https://t.co/sOSZoot3IY
1
2
2
We are recruiting a Quality Control Specialist to support GMP manufacturing of defined bacterial consortia in multiple phases of clinical development. Please share and apply to learn more! https://t.co/G3Y8RQfcnd
0
3
5
The Microbiome Therapeutic Innovation Group @MTIG_News members recently came together to write this minireview highlighting regulatory and analytical challenges in LBP development. This is a helpful primer for academics and early-stage microbiome therapeutics developers.
New Research: Navigating regulatory and analytical challenges in live biotherapeutic product development and manufacturing https://t.co/Tl7RSU2BbR
#FrontiersIn #Microbiomes
0
0
3
After months of hard work and collaboration, Congresswoman Yvette D. Clarke introduced the Peggy Lillis Clostridioides difficile Inclusion Act. Thank you Congresswoman Clarke for your work on this. Show your support for the bill here https://t.co/G5n5CzWDfA
2
4
9
Vedanta is recruiting a Senior Lab Ops Associate. Join our tight knit team of microbiologists, molecular biologists, immunologists, and folks in process/analytical development. Come help us advance defined bacterial consortia as a new drug modality! https://t.co/206lxiC7Yo
0
0
0
Great opportunity to learn more about C. difficile infection and microbiome-based therapies.
Registration now open for the Scientific Symposium debuting on 11/15/2024. This virtual event will allow clinicians, scientists, nurses, pharmacists, and industry to intermingle and update each other during C. diff Awareness Month. Register for free here https://t.co/yMyqZYgstB
0
0
0
Socioeconomic disparities and the prevalence of antimicrobial resistance Authors found spatial association between socioeconomic deprivation and AMR (AmpC & MRSA prevalence) https://t.co/D7gBr1kTkC
academic.oup.com
Antimicrobial resistance (AMR) and its spread poses a significant threat to health worldwide. By identifying locations with high AMR prevalence through geo
0
0
0